199 related articles for article (PubMed ID: 3871589)
1. Aztreonam: the first monobactam.
Sykes RB; Bonner DP
Am J Med; 1985 Feb; 78(2A):2-10. PubMed ID: 3871589
[TBL] [Abstract][Full Text] [Related]
2. Relation of structural properties of beta-lactam antibiotics to antibacterial activity.
Neu HC
Am J Med; 1985 Aug; 79(2A):2-13. PubMed ID: 3895915
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity of RU44790, a new N-tetrazolyl monocyclic beta-lactam.
Chantot JF; Klich M; Teutsch G; Bryskier A; Collette P; Markus A; Seibert G
Antimicrob Agents Chemother; 1992 Aug; 36(8):1756-63. PubMed ID: 1416860
[TBL] [Abstract][Full Text] [Related]
4. Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria.
Sykes RB; Bonner DP; Bush K; Georgopapadakou NH
Antimicrob Agents Chemother; 1982 Jan; 21(1):85-92. PubMed ID: 6979307
[TBL] [Abstract][Full Text] [Related]
5. Discovery and development of the monobactams.
Sykes RB; Bonner DP
Rev Infect Dis; 1985; 7 Suppl 4():S579-93. PubMed ID: 3909315
[TBL] [Abstract][Full Text] [Related]
6. SQ 26,180, a novel monobactam. I Taxonomy, fermentation and biological properties.
Wells JS; Trejo WH; Principe PA; Bush K; Georgopapadakou N; Bonner DP; Sykes RB
J Antibiot (Tokyo); 1982 Feb; 35(2):184-8. PubMed ID: 6978877
[TBL] [Abstract][Full Text] [Related]
7. In vitro antibacterial activity and interactions with beta-lactamases and penicillin-binding proteins of the new monocarbam antibiotic U-78608.
Zurenko GE; Truesdell SE; Yagi BH; Mourey RJ; Laborde AL
Antimicrob Agents Chemother; 1990 May; 34(5):884-8. PubMed ID: 2193625
[TBL] [Abstract][Full Text] [Related]
8. Emergence of resistance in gram-negative bacteria: a risk of broad-spectrum beta-lactam use.
Dworzack DL
Drug Intell Clin Pharm; 1986; 20(7-8):562-7. PubMed ID: 3488894
[TBL] [Abstract][Full Text] [Related]
9. Interaction of non-lytic beta-lactams with penicillin-binding proteins in Streptococcus pneumoniae.
Hakenbeck R; Tornette S; Adkinson NF
J Gen Microbiol; 1987 Mar; 133(3):755-60. PubMed ID: 3309169
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms by which imipenem may overcome resistance in gram-negative bacilli.
Williams RJ; Yang YJ; Livermore DM
J Antimicrob Chemother; 1986 Dec; 18 Suppl E():9-13. PubMed ID: 3493237
[TBL] [Abstract][Full Text] [Related]
11. Penicillin-binding proteins and the future of beta-lactam antibiotics. The Seventh Fleming Lecture.
Spratt BG
J Gen Microbiol; 1983 May; 129(5):1247-60. PubMed ID: 6352855
[No Abstract] [Full Text] [Related]
12. In vitro antibacterial properties of T-5575 and T-5578 novel parenteral 2-carboxypenams.
Watanabe Y; Minami S; Hayashi T; Araki H; Kitayama R; Ochiai H
Antimicrob Agents Chemother; 1995 Dec; 39(12):2787-91. PubMed ID: 8593021
[TBL] [Abstract][Full Text] [Related]
13. Aztreonam.
Childs SJ; Bodey GP
Pharmacotherapy; 1986; 6(4):138-52. PubMed ID: 3534798
[TBL] [Abstract][Full Text] [Related]
14. The in-vitro activity of Ro 17-2301, a new monobactam, compared with other antimicrobial agents.
Wise R; Andrews JM; Piddock LJ
J Antimicrob Chemother; 1985 Feb; 15(2):193-200. PubMed ID: 3980309
[TBL] [Abstract][Full Text] [Related]
15. Emergence of resistance during beta-lactam therapy of gram-negative infections. Bacterial mechanisms and medical responses.
Pechère JC
Drugs; 1988; 35 Suppl 2():22-8. PubMed ID: 3260854
[TBL] [Abstract][Full Text] [Related]
16. State of penicillin-binding proteins and requirements for their bactericidal interaction with beta-lactam antibiotics in Serratia marcescens highly resistant to extended-spectrum beta-lactams.
Gunkel AG; Hechler U; Martin HH
J Gen Microbiol; 1991 Feb; 137(2):243-52. PubMed ID: 2016583
[TBL] [Abstract][Full Text] [Related]
17. Ways to overcome cephalosporinase-mediated beta-lactam resistance in Enterobacter cloacae.
Then RL; Angehrn P
Chemioterapia; 1985 Feb; 4(1):83-9. PubMed ID: 3872727
[TBL] [Abstract][Full Text] [Related]
18. Penicillin-binding proteins and beta-lactamases: their effects on the use of cephalosporins and other new beta-lactams.
Neu HC
Curr Clin Top Infect Dis; 1987; 8():37-61. PubMed ID: 3077281
[TBL] [Abstract][Full Text] [Related]
19. Beta-lactam-fosfomycin antagonism involving modification of penicillin-binding protein 3 in Pseudomonas aeruginosa.
Reguera JA; Baquero F; Berenguer J; Martinez-Ferrer M; Martinez JL
Antimicrob Agents Chemother; 1990 Nov; 34(11):2093-6. PubMed ID: 2127343
[TBL] [Abstract][Full Text] [Related]
20. Quantitative relationship between sensitivity to beta-lactam antibiotics and beta-lactamase production in gram-negative bacteria--II. Non-steady-state treatment and progress curves.
Frère JM; Joris B; Crine M; Martin HH
Biochem Pharmacol; 1989 May; 38(9):1427-33. PubMed ID: 2655602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
